General Information of Drug (ID: DM15F0X)

Drug Name
Gefitinib Drug Info
Synonyms
Gefitini; IRE; Iressa; Irressat; Gefitinib [USAN]; ZD 1839; ZD1839; Iressa (TN); Iressa(TM); ZD-1839; CU-00000000396-1; Gefitinib,Iressa, ZD1839; Gefitinib (JAN/USAN/INN); ZD-1839, Iressa, Gefitinib; N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-amine; N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)-4-quinazolinamide; N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine; N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(morpholin-4-yl)propoxy]quinazolin-4-amine; N-(3-Chloro-4-fluoro-phenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine; 4-(3'-Chloro-4'-fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy)quinazoline; 6-(3-morpholinopropoxy)-N-(3-chloro-4-fluorophenyl)-7-methoxyquinazolin-4-amine
Indication
Disease Entry ICD 11 Status REF
Colon adenocarcinoma Approved [1]
Glioblastoma 2A00 Approved [1]
Lung cancer 2C25.0 Approved [1]
Non-small-cell lung cancer 2C25.Y Approved [1]
Rectal adenocarcinoma 2B92 Approved [1]
Rectum mucinous adenocarcinoma Approved [1]
Solid tumour/cancer 2A00-2F9Z Approved [2]
Head and neck cancer 2D42 Phase 3 [2]
Urethral cancer 2C93 Phase 2 [2]
Colon cancer 2B90.Z Investigative [1]
Colon mucinous adenocarcinoma Investigative [1]
Therapeutic Class
Anticancer Agents
Cross-matching ID
PubChem CID
123631
ChEBI ID
CHEBI:49668
CAS Number
184475-35-2
TTD ID
D09XZB
VARIDT ID
DR00423
INTEDE ID
DR0764
ACDINA ID
D00299

Full List of Drug Formulations Containing This Drug

Gefitinib 250 mg tablet
Company Formulation ID FDA Description
AstraZeneca F09080 Lactose monohydrate; Sodium lauryl sulfate; Magnesium stearate; Ferric oxide red; Ferric oxide yellow; Titanium dioxide; Croscarmellose sodium; Polyethylene glycol 300; Cellulose, microcrystalline; Hypromelloses; Povidones
------------------------------------------------------------------------------------

References

1 Gefitinib FDA Label
2 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4941).